Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 22,079,795 5.140% |
-2,862,750 (-11.48%) |
Filing History |
| 2021-02-12 7:11 pm Purchase |
2020-12-31 | 13G | Royalty Pharma plc RPRX |
GENERAL ATLANTIC PARTNERS LLC | 26,243,870 6.400% |
26,243,870 (New Position) |
Filing History |
| 2021-02-11 07:52 am Sale |
2020-12-31 | 13G | Royalty Pharma plc RPRX |
ADAGE CAPITAL PARTNERS GP LLC | 38,714,280 9.970% |
-7,301,050 (-15.87%) |
Filing History |
| 2021-02-10 4:05 pm Purchase |
2021-01-29 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
46,144,883 11.900% |
22,547,596 (+95.55%) |
Filing History |
| 2021-02-09 4:53 pm Purchase |
2020-12-31 | 13G | Royalty Pharma plc RPRX |
MORGAN STANLEY MS |
23,597,287 6.100% |
23,597,287 (New Position) |
Filing History |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Royalty Pharma plc RPRX |
FMR CORP | 24,942,545 6.426% |
24,942,545 (New Position) |
Filing History |
| 2020-06-29 6:36 pm Purchase |
2020-06-18 | 13D | Royalty Pharma plc RPRX |
Giuliani Mario Germano | 46,316,170 12.700% |
46,316,170 (New Position) |
Filing History |
| 2020-06-24 4:54 pm Purchase |
2020-06-18 | 13G | Royalty Pharma plc RPRX |
ADAGE CAPITAL PARTNERS GP LLC | 46,015,330 12.580% |
46,015,330 (New Position) |
Filing History |